https://www.selleckchem.com/pr....oducts/santacruzamat
This inhibitory profile makes FB9s-b a powerful template for developing tool molecules and drug candidates for treatment of neurological diseases involving excessive activities of the GluK1 and GluK2 subunits. Published under license by The American Society for Biochemistry and Molecular Biology, Inc.The dextransucrase DSR-OK from the Gram-positive bacterium Oenococcus kitaharae DSM17330 produces the dextran of the highest molar mass reported to date (~109 g/mol). In this study, we selected a recombinant form, DSR-OKΔ1
Mi piace
Commento
Condividi
